TABLE 3.
Characteristics and baseline variables for patients with and without persistent symptoms.
| No. (%)a |
||||
|---|---|---|---|---|
| Characteristic | Persistent symptoms (n = 152) | No persistent symptoms (n = 283) | Total (N = 435)b | P value |
| Age | 0.50 | |||
| Median (range) | 52 (20–99) | 55 (18–90) | 54 (18–99) | |
| Sex | <0.001 | |||
| Female | 110 (72.4) | 152 (53.7) | 262 (60.2) | |
| Male | 42 (27.6) | 131 (46.3) | 173 (39.8) | |
| Were you hospitalized for your illness? | 0.08 | |||
| No. missing | 1 | 0 | 1 | |
| No | 128 (84.8) | 256 (90.5) | 384 (88.5) | |
| Yes | 23 (15.2) | 27 (9.5) | 50 (11.5) | |
| Did you experience any negative psychological impact, such as anxiety or depression, from COVID-19? | <0.001 | |||
| No. missing | 1 | 1 | 2 | |
| No | 72 (47.7) | 213 (75.5) | 285 (65.8) | |
| Yes | 79 (52.3) | 69 (24.5) | 148 (34.2) | |
| Were you symptom free for any period before new symptoms started? | 0.48 | |||
| No. missing | 20 | 142 | 162 | |
| No | 96 (72.7) | 97 (68.8) | 193 (70.7) | |
| Yes | 36 (27.3) | 44 (31.2) | 80 (29.3) | |
| Was it less or more than 1 month before you felt able to resume normal activities? | <0.001 | |||
| No. missing | 4 | 3 | 7 | |
| Less than 1 month | 73 (49.3) | 231 (82.5) | 304 (71.0) | |
| More than 1 month | 75 (50.7) | 49 (17.5) | 124 (29.0) | |
a
Data are presented as No. (%) unless otherwise indicated.
b
Two patients did not record persistent symptoms, leaving 435 patients to be included in this analysis.